Kansas City, MO (PRWEB) June 14, 2013
The birth control safety advocates at DrugRisk.com are announcing new information on the site for women who have used the vaginal ring contraceptive NuvaRing. A federal panel recently ruled that five patients filing cases in California alleging blood clot injuries will have to join the multi-district litigation in Missouri*.
DrugRisk was created to improve the safety of patients using popular prescription drugs and devices by providing the latest warnings, research, legal news and recalls. Visitors can find out if others are experiencing similar side effects and decide if they need legal advice.
Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots**.
With over a thousand patients filing a NuvaRing lawsuit alleging blood clots, many cases were consolidated to a special federal court in Missouri. The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.
Recently, DrugRisk learned that five patients filed claims in Illinois*** and others attempted to have their cases heard in California*. However, the Judicial Panel on Multidistrict Litigation has ordered that the cases be combined with the current litigation in Missouri, where trials are scheduled to start in October****.
Anyone who suffered a blood clot, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible.
Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawy
Copyright©2012 Vocus, Inc.
All rights reserved